CONTINUED PROCESS VERIFICATION (CPV) INFORMATICS SYSTEMS AND VALIDATION

Size: px
Start display at page:

Download "CONTINUED PROCESS VERIFICATION (CPV) INFORMATICS SYSTEMS AND VALIDATION"

Transcription

1 CONTINUED PROCESS VERIFICATION (CPV) INFORMATICS SYSTEMS AND VALIDATION OUTPUT FROM BIOPHORUM OPERATIONS GROUP (BPOG) COLLABORATION OF BIOTECH COMPANIES Carly Cox, Process Informatics Manager, Pfizer on behalf of BPOG CPV Team

2 Outline 1. Background on BPOG and CPV/I Team 2. Validation Scope 3. Data Integrity 4. Risk-Based Approach 5. Optimized Testing 6. Change Management 7. Conclusions 2

3 1. Background BioPhorum Operations Group (BPOG) BioPhorum BioPhorum Development Group CPV and Informatics Team Industry-wide collaboration on BioPharma drug substance operations Started in member companies, over 1000 participants Networking and best practice sharing Regular teleconferences/web meetings and periodic face-to-face meetings Established industry best practices on a wide range of quality, engineering and organizational topics considered central to the challenge of mastering effective biotech drug substance operations 3

4 1. Background BPOG CPV and Informatics Team FDA releases process validation guidance with CPV BPOG CPV team formed BPOG CPV Informatics team formed BPOG CPV case study published BPOG CPV and Informatics teams merged BPOG roadmap for CPV implementation published BPOG responses to signals paper published BPOG legacy products paper due for publication BPOG CPV informatics system paper due for publication 4

5 2. Validation Scope Source Systems User Interaction CPV System Data Preparation and Aggregation Analyses Reports 5

6 3. Data Integrity What is Required Source Systems Data from CPV system must match data from the source systems CPV System Statistical and graphical outputs from CPV system must match data 6

7 3. Data Integrity How to Achieve Effort Fully Automated Cumulative Automated Fully Manual Cumulative Manual Time 7

8 4. Risk-Based Approach Risk Priority = Severity x Probability x Detectability Depends on intended use Depends on system design Depends on system design Risk-based orientation is a guiding principle of the FDA s CGMPs for the 21 st Century Initiative 1 Severity Examples Probability Examples Detectability Examples High OOS batch released High >10% chance Low Very hard to detect Medium GMP document incorrect Medium 1-10% chance Medium Can detect, but takes effort Low Time wasted Low <1% chance High Easily detected 1 Pharmaceutical CGMPs for the 21st century - A Risk-Based Approach 8

9 4. Risk-Based Approach Severity Low Medium High Risk Class High Medium Low Risk Priority = Severity x Probability x Detectability Probability Detectability High Medium Low Method of Transfer Automated Manual Risk Class Source System Type GMP Non-GMP CPV System Procedures Well-designed Non-existent 1 M H H 2 L M H 3 L L M Source Change Notification Priority Automated Manual None Atypical Data Notification Automated Manual None Manual Entry Verification Blinded Visual None 9

10 5. Optimized Testing System Design 1 Create reusable core objects Create configuration libraries Maximize use of master data 3 Core 2 Documentation Leverage from vendor Eliminate redundancy Procedures for routine tasks Testing Leverage from vendor Leverage procedures Align testing to risk priority Risk Priority High Medium Low Level of Testing Positive and negative; Objective evidence or second person verification Positive testing; Clear documentation Minimal testing; Pass/Fail Only 10

11 6. Change Management Why it matters CPV Plan LIMS System Investigation System Software Configurations CPV System Hardware Instruments Batch Records ERP System Control Historian System 11

12 6. Change Management - Awareness Proactive notifications Change controls Master data change requests Document revisions Investigations Automated reactive notifications Master data comparisons Duplicate data checks Missing data checks =? AVOID MANUAL REACTIVE NOTIFICATIONS! 12

13 6. Change Management - Efficiency Reduce documentation Re-use configurations 1 3 Core 2 Recycle impact assessments 13

14 Severity Risk Class Effort 7. Conclusion Validation Scope Data Integrity Probability Time Detectability Risk-Based Approach L M H H M H H M L M H L L L M Risk Class H M L 1 M H H 2 L M H 3 L L M Priority Optimized Testing 3 1 Core 2 Change Management Investigati on System Configurati ons CPV Plan Software CPV System Hardware LIMS System Instrument s Batch Records ERP System Control System Historian 14

15 Questions 15

Principal approach to CPV :

Principal approach to CPV : Principal approach to CPV : Integration with Quality Systems & Operating Mechanisms J. Gampfer, Baxalta, Vienna Austria Baxalta Principal Approach to CPV J. Gampfer Page 1 Baxalta Principal Approach to

More information

An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies. SPEAKER: Suzanne Murray Biogen

An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies. SPEAKER: Suzanne Murray Biogen An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies SPEAKER: Suzanne Murray Biogen Contents 1. BioPhorum Operations Group (BPOG) and the Post-approvals

More information

Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement. Copyr i ght 2014 O SIs oft, LLC.

Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement. Copyr i ght 2014 O SIs oft, LLC. Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement Presented by Nick Alexiades - Sanofi About Sanofi Sanofi, a diversified global healthcare leader, discovers,

More information

Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement

Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement Enablement and Standardization of Advanced Process Data Technologies with an Enterprise Agreement Presented by Jason Valenta, Tim Alosi, Nick Alexiades Genzyme/Sanofi Introductions Jason Valenta EA Program

More information

An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America

An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America An Industry Perspective: Reducing the Complexity and Impact of Regulatory Changes in Latin America SPEAKERS: Janett Mugaburu-Richards, M.S. Pfizer Inc. Kavita Ramalingam Iyer, Ph.D Merck & Co., Inc. Contents

More information

PRESS INFORMATION No. 04/2014 August 2014

PRESS INFORMATION No. 04/2014 August 2014 PRESS INFORMATION No. 04/2014 August 2014 Atris Information Systems GmbH. Kartaeuserstr. 49. D-79102 Freiburg Experience with System-supported Continued Process Verification by Peter Trochim Since January

More information

Compliance and qualification services. Trust your validation needs to the people who design, build, test, and support your systems

Compliance and qualification services. Trust your validation needs to the people who design, build, test, and support your systems Compliance and qualification services Trust your validation needs to the people who design, build, test, and support your systems Validation can be challenging If your laboratory is required to qualify

More information

BMC FootPrints. Service Management Solution Overview.

BMC FootPrints. Service Management Solution Overview. BMC FootPrints Service Management Solution Overview www.rightstar.com BMC FootPrints Service Management Key Benefits Single pane of glass: Single, web-based entry point for all of your Service and Asset

More information

Ensure Data Integrity Compliance Enterprise-Wide

Ensure Data Integrity Compliance Enterprise-Wide Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition

More information

Batch Manufacturing in the Biopharmaceutical Environment

Batch Manufacturing in the Biopharmaceutical Environment Presented at the World Batch Forum North American Conference Chicago, IL May 16-19, 2004 900 Fox Valley Drive, Suite 204 Longwood, FL 32779-2552 +1.407.774.0207 Fax: +1.407.774.6751 E-mail: info@wbf.org

More information

Synopsis: FDA Process Validation Guidance

Synopsis: FDA Process Validation Guidance Synopsis: FDA Process Validation Guidance This synopsis is a comparison of the draft version 2008 and the final version 2011 of the U.S. FDA Guidance Process Validation: General Principles and Practices.

More information

ISPE Product Show Quality Systems in the 21 st Century

ISPE Product Show Quality Systems in the 21 st Century ISPE Product Show Quality Systems in the 21 st Century Theresa McCarthy Dr. Byron Mattingly 7 October 2015 3:30 pm 4:30 pm Agenda Introductions What Schools are here today? What Majors? Overview of Quality

More information

Preventing Errors with a Mobile MES

Preventing Errors with a Mobile MES AADECA JORNADA TECNICA MES* EN INDUSTRIA FARMACEUTICA 14/05/2010 *MANUFACTURING ENTERPRISE SYSTEMS ISPE Preventing Errors with a Mobile MES Agenda Manufacturing Challenges - MES Benefits MES Systems Purpose

More information

Leveraging PI ACE as Enabler in a Plant Manufacturing Execution System

Leveraging PI ACE as Enabler in a Plant Manufacturing Execution System Leveraging PI ACE as Enabler in a Plant Manufacturing Execution System Presented by Roberto Gubellini, Mauro Misuri Eli Lilly Italia Pierre Menard Global Automation Partners 2 Agenda and Global Automation

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

APM Health Classic from GE Digital Part of our On-Premise Asset Performance Management Classic Solution Suite

APM Health Classic from GE Digital Part of our On-Premise Asset Performance Management Classic Solution Suite Drives rapid situational adjustments with decision-quality information based on comprehensive knowledge of asset conditions Asset-intensive companies often struggle with a lack of visibility into physical

More information

THE PACMP STRATEGY. March 13-16, 2018

THE PACMP STRATEGY. March 13-16, 2018 THE PACMP STRATEGY FDA/Xavier PharmaLink Conference 2018 March 13-16, 2018 Ajay Pazhayattil, Director- Pharmaceutical Development, AvacaPharma Inc., Vienna, VA ajay.pazhayattil@avacapharma.com PACMP ICH

More information

PHARMA CATCHES ON TO CONTINUOUS MANUFACTURING

PHARMA CATCHES ON TO CONTINUOUS MANUFACTURING 01 PHARMA CATCHES ON TO CONTINUOUS MANUFACTURING Support from the FDA, industry groups and automation suppliers is helping pharmaceutical companies break the batch habit in favor of a continuous approach

More information

AN ENTIRELY NEW PROCESS- AND EXECUTION- CENTRIC APPROACH TO LIMS IMPLEMENTATIONS

AN ENTIRELY NEW PROCESS- AND EXECUTION- CENTRIC APPROACH TO LIMS IMPLEMENTATIONS DATASHEET ACCELRYS LIMS AN ENTIRELY NEW PROCESS- AND EXECUTION- CENTRIC APPROACH TO LIMS IMPLEMENTATIONS Accelrys LIMS is purpose-built to manage 21st-century product and process informatics requirements

More information

Summary. Days til Cutover Considerations Detail Sheet

Summary. Days til Cutover Considerations Detail Sheet Summary Number Task Name 1 Prepare and document Production environment Days til Cutover Considerations Detail Sheet 21 Complete configuration of the hardware and 1. Production Env software for the production

More information

PPTA Regulatory Workshop June 13, 2016

PPTA Regulatory Workshop June 13, 2016 PPTA Regulatory Workshop June 13, 2016 W. BRYAN SILVEY W. Bryan Silvey is the Senior Director, Global Regulatory Affairs/CMC for Baxalta US Inc. He is located at Baxalta s Westlake Village California regional

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Become a truly service-oriented organization

Become a truly service-oriented organization Overview Solution highlights Single pane of glass: Single, webbased entry point for all service desk and desktop management needs Joined up processes: Integrated process automation across incident, problem,

More information

James B. Powers, Jr. MSA, BS-BioChem Managing Partner, BAI

James B. Powers, Jr. MSA, BS-BioChem Managing Partner, BAI MSA, BS-BioChem Managing Partner, BAI MSA, BS-BioChem Partner James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience. James is a proactive leader, designer

More information

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum IT Compliance in the FDA Regulated Industry IT & Automation Forum November 13, 2007 Caribe Hilton, San Juan Puerto Rico Speaker: Mr. Juan O. Pérez, Principal Consultant joperez@fdcpr.com IT Responsibilities

More information

GAMP5 Validation for Dynamics 365

GAMP5 Validation for Dynamics 365 GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning

More information

Clare Simpson 21 st November Content courtesy of Steve Jones, Paul Illot, Bert Frohlich, Thomas Ryll Biopharm Services

Clare Simpson 21 st November Content courtesy of Steve Jones, Paul Illot, Bert Frohlich, Thomas Ryll Biopharm Services Modelling a technology roadmap for acceleration of global industry innovation Presentation to Wales Life Science Hub, Health Economics Special Interest Group Clare Simpson 21 st November 2016 Content courtesy

More information

2 nd Annual Shipping Performance Benchmark Survey

2 nd Annual Shipping Performance Benchmark Survey 2 nd Annual Shipping Performance Benchmark Survey Summation Results 2 nd Annual Kewill Interactive Survey February 2008 Kewill 2008 Contents Objectives of the Survey Key Areas of Improvement Carrier Management

More information

About Pfizer. Founded 1849 Headquarters New York, New York. Enterprise Value (1) $209.75B Employees 78,300

About Pfizer. Founded 1849 Headquarters New York, New York. Enterprise Value (1) $209.75B Employees 78,300 About Pfizer Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Key disease areas of focus in Oncology, Biosimilars, Inflammation and

More information

Towards a Recipe Driven Organization

Towards a Recipe Driven Organization Towards a Recipe Driven Organization Presented by Jim Kenyon, Pharmaceutical Development and Manufacturing Sciences, Janssen Research and Development, LLC Copyright 2013 OSIsoft, LLC. Overview Introduction

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

Ensuring An Effective Quality System. M. Kowolenko, Ph.D. SVP, Biopharmaceutical Operations & Technology

Ensuring An Effective Quality System. M. Kowolenko, Ph.D. SVP, Biopharmaceutical Operations & Technology Ensuring An Effective Quality System M. Kowolenko, Ph.D. SVP, Biopharmaceutical Operations & Technology Role of the Quality Unit Compliance with all relevant regulations and commitments made in license

More information

MDI Manufacturing Services

MDI Manufacturing Services MDI Manufacturing Services Presenter, Date Who we are 3M Drug Delivery Systems is a division of 3M dedicated to working together with pharmaceutical and biotech companies to bring new and improved products

More information

Managing Validation. Paperless Recorders

Managing Validation. Paperless Recorders Managing Validation Paperless Recorders Multitrend Plus Validation Background The past five years has seen an increase in the use of computerized systems and products in the pharmaceutical and bio-pharmaceutical

More information

Achieve greater efficiency in asset management by managing all your asset types on a single platform.

Achieve greater efficiency in asset management by managing all your asset types on a single platform. Asset solutions To support your business objectives Achieve greater efficiency in asset by managing all your asset types on a single platform. Obtain an entirely new level of asset awareness Every company

More information

ICH Q10/WHO TRS A Regulatory Perspective

ICH Q10/WHO TRS A Regulatory Perspective Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique

More information

The emdr Requirement. Best Practices for Enhancing Collaboration with the FDA

The emdr Requirement. Best Practices for Enhancing Collaboration with the FDA The emdr Requirement Best Practices for Enhancing Collaboration with the FDA Executive Summary The Food and Drug Administration (FDA) is tasked with the job of ensuring that all products produced within

More information

Robert Posgai Director of Materials Procurement, Biogen (BPOG)

Robert Posgai Director of Materials Procurement, Biogen (BPOG) Keynote Speaker Building the Foundations for Excellence in Biopharmaceutical Raw Material Supply Chain and Impact of Modality on Excipient Expectations Robert Posgai Director of Materials Procurement,

More information

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd.

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd. Guidance for Industry Process Validation: General Principles and Practices D M k T k Dr. Mark Tucker, F. Hoffman-La Roche, Ltd. Disclosures I am currently a Senior Technical Advisor at F. Hoffman -La Roche.

More information

Get Excellent Performance. Good Engineering Practice Howard Sneider, CPIP Process, CRB. Agenda

Get Excellent Performance. Good Engineering Practice Howard Sneider, CPIP Process, CRB. Agenda Get Excellent Performance from Good Engineering Practice Howard Sneider, CPIP Process, CRB Agenda Part 1: Engineering Practice good engineering practice Part 2: Good Engineering Practice Part 3: Getting

More information

International Journal of Pharmaceutical and Medicinal Research

International Journal of Pharmaceutical and Medicinal Research Review article A review on process validation Int. J. Pharm. Med. Res. 2014; 2(3):100-104 ISSN: 2347-7008 International Journal of Pharmaceutical and Medicinal Research Journal homepage: www.ijpmr.org

More information

WHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED?

WHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED? WHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED? GREAT SCIENCE IS BUILT ON LABORATORY-WIDE COMPLIANCE Navigating the complexities of global regulatory entities and requirements can be difficult, and the penalties

More information

Implementation Best Practices

Implementation Best Practices QM Functionality in SAP ERP: Implementation Best Practices Mike Krug October 6, 2011 www.qmsinc.com Agenda Introduction to QMS and Our Team SAP Software: Quality Overview Implementation Best Practices

More information

PAT/QbD Bringing Pharma into the 21 st Century. Creating Innovations for the Pharmaceutical Industry. usa.siemens.com/pharma

PAT/QbD Bringing Pharma into the 21 st Century. Creating Innovations for the Pharmaceutical Industry. usa.siemens.com/pharma PAT/QbD Bringing Pharma into the 21 st Century Creating Innovations for the Pharmaceutical Industry usa.siemens.com/pharma The pharmaceutical industry is headed for fundamental changes within the next

More information

Welcome to our E-Seminar: Automation Tools for Efficient Result Review According to GMP

Welcome to our E-Seminar: Automation Tools for Efficient Result Review According to GMP Welcome to our E-Seminar: Automation Tools for Efficient Result Review According to GMP Overview Overview Chapter Page Overview The sample lifecycle 6 Chromatographic data system and the sample life cycle

More information

Process Validation Guidelines. Report highlights 23 rd February 2018

Process Validation Guidelines. Report highlights 23 rd February 2018 Process Validation Guidelines Report highlights 23 rd February 2018 Process validation is an important element of pharmaceutical quality system An effective system provides assurance of the continued capability

More information

Experion Batch Product Note

Experion Batch Product Note Connected Plant Experion Batch Product Note Experion Batch combines compact Experion distributed control, batch automation, and advanced visualization technology for a solution optimized for pharmaceutical,

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

Downtime Solutions Batch Management

Downtime Solutions Batch Management Downtime Solutions Batch Management INCREASE PRODUCTIVITY AND QUALITY WHILST ACHIEVING SIGNIFICANT COST SAVINGS With the market demanding faster deliveries, lower prices and higher quality, you need a

More information

A Taxonomy for Test Oracles

A Taxonomy for Test Oracles A Taxonomy for Test Oracles Quality Week 98 Douglas Hoffman Software Quality Methods, LLC. 24646 Heather Heights Place Saratoga, California 95070-9710 Phone 408-741-4830 Fax 408-867-4550 Copyright 1998,

More information

Compliance in Multiple Regulatory Settings. a Holistic Approach

Compliance in Multiple Regulatory Settings. a Holistic Approach Compliance in Multiple Regulatory Settings a Holistic Approach Vanessa Balogh Key Problems Compliance with multiple regulations FDA, SOX, HIPAA,GLBA,BASEL II, PCI, more Lack of transparency, ownership

More information

Benefits. + + Consistent quality to recipe specification. + + Increase asset utilization and operational efficiency

Benefits. + + Consistent quality to recipe specification. + + Increase asset utilization and operational efficiency Wonderware InBatch Flexible Batch Management Wonderware InBatch software enables sophisticated equipment arbitration and concurrent batch execution capabilities to maximize asset utilization, plant throughput

More information

Enterprise Architecture May 2015 Executive Committee. May 20, 2015 Wednesday 1:00-2:00 p.m. 561 Smith Center

Enterprise Architecture May 2015 Executive Committee. May 20, 2015 Wednesday 1:00-2:00 p.m. 561 Smith Center Enterprise Architecture May 2015 Executive Committee May 20, 2015 Wednesday 1:00-2:00 p.m. 561 Smith Center Agenda Meeting Purpose and Intended Outcomes The Interoperability Problem: Current State (15

More information

A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION

A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION A COMPARATIVE FRAMEWORK BETWEEN NEW PRODUCT & LEGACY PRODUCT PROCESS VALIDATION By Mark Mitchell, Principal Consultant, Process and Engineering, Pharmatech Associates, Inc. PHARMATECH WHITE PAPER.DOCX

More information

Top 6 Challenges of the Pharmaceutical Manufacturing Industry & Their Solutions

Top 6 Challenges of the Pharmaceutical Manufacturing Industry & Their Solutions Attn: Pharmaceutical Manufacturers and CMOs Top 6 Challenges of the Pharmaceutical Manufacturing Industry & Their Solutions The pharmaceutical manufacturing industry is undergoing fast paced change in

More information

James B. Powers, Jr. MSA, BS-BioChem Partner. James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience.

James B. Powers, Jr. MSA, BS-BioChem Partner. James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience. MSA, BS-BioChem Partner James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience. James is a proactive leader, designer and implementer of compliance / GMP

More information

ERP for Pharmaceutical Industry (Microsoft Dynamics AX) Global trends and business challenges A new generation of enterprise resource planning (ERP)

ERP for Pharmaceutical Industry (Microsoft Dynamics AX) Global trends and business challenges A new generation of enterprise resource planning (ERP) ERP for Pharmaceutical Industry (Microsoft Dynamics AX) Prateep Juavijitjan Vantage Business Solutions Our Agenda Today Global business imperatives Global trends and business challenges A new generation

More information

EQMS Coexistence in an Enterprise Environment. Best Practices to Managing Quality Processes

EQMS Coexistence in an Enterprise Environment. Best Practices to Managing Quality Processes EQMS Coexistence in an Enterprise Environment Best Practices to Managing Quality Processes 1Introduction IT System 3 Quality System Processes Benefits of EQMS 5Resources Introduction Organizations have

More information

ABB ServicePro 4.0 Service Management System

ABB ServicePro 4.0 Service Management System ABB ServicePro 4.0 Service Management System Presented by Paul Radcliffe PS Service June 6, 2014 Slide 1 Questions customers ask How successful is my maintenance program? - Am I performing the right PM

More information

GOING PAPERLESS FROM LAB TO PLANT

GOING PAPERLESS FROM LAB TO PLANT TECHNOLOGY BRIEF GOING PAPERLESS FROM LAB TO PLANT Capturing and harmonizing data in product R&D and manufacturing/quality facilities to improve Operational Excellence THE CHANGING ROLE OF INFORMATICS

More information

3M Drug Delivery Systems. April 26, 2011

3M Drug Delivery Systems. April 26, 2011 3M MDI Manufacturing April 26, 2011 3M Drug Delivery Systems Drug Delivery Systems Overview 3M Drug Delivery Systems is a division of 3M that is dedicated to the development and manufacturing of inhalation

More information

Electronic Resources Workflow Analysis & Process Improvement Phase II

Electronic Resources Workflow Analysis & Process Improvement Phase II Electronic Resources Workflow Analysis & Process Improvement Phase II Rosalyn R. Raeford & Beverly Dowdy Duke University Libraries 2013 Workflow Analysis: Problems Identified 1. Effective communication

More information

Agile Implementation of LIMS Software Reduce Validation or Verification Effort and Meet GAMP 5 Standards

Agile Implementation of LIMS Software Reduce Validation or Verification Effort and Meet GAMP 5 Standards Lechbrucker Straße 31 81476 München E-Mail: Thomas.@Lueftl.com Telefon: +49 89 74654898 Mobil: +49 172 68 36 030 Fax: +49 3212 1298171 www.lueftl.com Agile Implementation of LIMS Software Reduce Validation

More information

LABORATORY COMPLIANCE

LABORATORY COMPLIANCE 1 LABORATORY COMPLIANCE Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills, MI INTRODUCTION Implementation of the Systems-Based Inspection Guideline for drug manufacturers in

More information

Pharmaceutical cgmps for the 21st Century February 2004

Pharmaceutical cgmps for the 21st Century February 2004 Pharmaceutical cgmps for the 21st Century February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample FDA GxP Regulations Along the Drug Life Basic Research

More information

Implementation of xem for Emissions Management at a Petrochemical Company. David Ocamb, NOVA Chemicals CISUG Conference 18 April 2006

Implementation of xem for Emissions Management at a Petrochemical Company. David Ocamb, NOVA Chemicals CISUG Conference 18 April 2006 Implementation of xem for Emissions Management at a Petrochemical Company David Ocamb, NOVA Chemicals CISUG Conference 18 April 2006 Page 2 Agenda - Corporate Profile & Commitment to Environment - Data

More information

Risk Based Validation. Why, How and with what tools?

Risk Based Validation. Why, How and with what tools? Risk Based Validation Why, How and with what tools? Tech Talk Agenda History of FDA GMP initiative for the 21 st Century. Industry response to FDA initiative. Harmonisation through ICH. ASTM Standard on

More information

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing

More information

Yphise portfolio of valuable projects

Yphise portfolio of valuable projects Yphise portfolio of valuable projects Independent investment recommandations since 1985 Software Project EXECUTIVE WHITE PAPER SUCCEEDING WITH PROACTIVE IT With ASG s metacmdb BSC Business Strategy and

More information

Innovative strategies to improve R&D ROI

Innovative strategies to improve R&D ROI Innovative strategies to improve R&D ROI Ed Stelmakh, CPA, CMA Vice President and CFO Otsuka America Pharmaceutical, Inc. DISCLAIMER: The following presentation represents the opinions of the speaker and

More information

Developing Temperature Controlled Environmental Test Standards

Developing Temperature Controlled Environmental Test Standards Developing Temperature Controlled Environmental Test Standards 1 Ed Church Executive Director 2 nd Annual Biotech Supply Chain Academy 2 History ISTA Pioneered Packaging Performance Testing Procedures

More information

Resident Engineering Services - Business Model & Success Story

Resident Engineering Services - Business Model & Success Story Slide 1 Resident Engineering Services - Business Model & Success Story Alynn Burk Jamie Koehler Mirko Canel Genentech 2013 Invensys. All Rights Reserved. The names, logos, and taglines identifying the

More information

Don't miss your cgmp guidelines. Follow your manufacturing operations the ion Way

Don't miss your cgmp guidelines. Follow your manufacturing operations the ion Way Don't miss your cgmp guidelines. Follow your manufacturing operations the ion Way Access to processed information anywhere anytime at affordable cost is the key success factor Mr. Shejil Balakrishnan,

More information

OUR SOLUTIONS. SafetyChain is a Quality Management. System (QMS) that helps food. and beverage companies improve

OUR SOLUTIONS. SafetyChain is a Quality Management. System (QMS) that helps food. and beverage companies improve SafetyChain is a Quality Management System (QMS) that helps food and beverage companies improve productivity, profitability and compliance with a flexible, user-friendly software platform that captures,

More information

H23271, page 1 Job Description Non-Career Sr. Enterprise Architect H24 Ronald Reagan Washington National Airport

H23271, page 1 Job Description Non-Career Sr. Enterprise Architect H24 Ronald Reagan Washington National Airport H23271, page 1 Job Description Non-Career Sr. Enterprise Architect H24 Nothing in this job description restricts management's right to assign or reassign duties and responsibilities to this job at any

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

Delivery of materials (usually finished product from a distribution center) to a first paying customer external to Site

Delivery of materials (usually finished product from a distribution center) to a first paying customer external to Site Title: Cold Chain Management of Biopharmaceutical Materials Guidance Number: 122 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Introduction The risk of compromising

More information

Better information, better results siemens.com/xhq

Better information, better results siemens.com/xhq XHQ Operations Intelligence Better information, better results siemens.com/xhq XHQ Operations Intelligence Siemens Product Lifecycle Management Software, Inc. Faster, fact-based decision-making Delivering

More information

PRODUCTION AND PERFORMANCE MANAGEMENT DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT IN THE REGULATED INDUSTRIES

PRODUCTION AND PERFORMANCE MANAGEMENT DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT IN THE REGULATED INDUSTRIES PRODUCTION AND PERFORMANCE MANAGEMENT DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT IN THE REGULATED INDUSTRIES DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT DATA HISTORIANS FOR INCIDENT

More information

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

Enabling Improvement through the Product Lifecycle: Change Management within a PQS Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,

More information

GE Intelligent Platforms. Operational Excellence

GE Intelligent Platforms. Operational Excellence GE Intelligent Platforms Operational Excellence Drive Operational Excellence in manufacturing Continuous improvements in key areas of your operations can help you reduce manufacturing costs, protect profit

More information

Reducing the Time to Market with an eclinical System

Reducing the Time to Market with an eclinical System Reducing the Time to Market with an eclinical System Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright

More information

Data Infrastructure and Analytics in Life Sciences

Data Infrastructure and Analytics in Life Sciences Data Infrastructure and Analytics in Life Sciences Presented by Petter Moree Industry Principal Life Sciences, Food & Beverage and Specialty Chemicals Time Title Presenter(s) 9:00 9:30 Data Infrastructure

More information

21CFR11 Compliance and Automated Manufacturing

21CFR11 Compliance and Automated Manufacturing Presented at the World Batch Forum North American Conference Woodcliff Lake, NJ April 7-10, 2002 107 S. Southgate Drive Chandler, Arizona 85226-3222 480-893-8803 Fax 480-893-7775 E-mail: info@wbf.org www.wbf.org

More information

GE Digital Consistency, Efficiency and Accountability. Water Solutions

GE Digital Consistency, Efficiency and Accountability. Water Solutions GE Digital Consistency, Efficiency and Accountability Water Solutions 1 Water Utilities spend over $1,000,000,000 on controls and IT every year with the goal of increasing operational efficiency, consistency

More information

EVM-11-G-001 Does the tool use ITIL 2011 Edition process terms and align to ITIL 2011 N/A. Edition workflows and process integrations?

EVM-11-G-001 Does the tool use ITIL 2011 Edition process terms and align to ITIL 2011 N/A. Edition workflows and process integrations? Purpose: [M]anage events throughout their lifecycle. This lifecycle of activities to detect events, make sense of them and determine the appropriate control action is coordinated by the event management

More information

Process ERP, an ideal software solution for Life Science industries

Process ERP, an ideal software solution for Life Science industries Process ERP, an ideal software solution for Life Science industries Update on FDA's current compliance requirements of GxP regulated computerized systems Ravi Jotwani, Ph.D University of Louisville ProcessManufacturingSoftware

More information

Chapter 6. Supporting Processes with ERP Systems. Copyright 2015 Pearson Education, Inc. 6-1

Chapter 6. Supporting Processes with ERP Systems. Copyright 2015 Pearson Education, Inc. 6-1 Chapter 6 Supporting Processes with ERP Systems Copyright 2015 Pearson Education, Inc. 6-1 Learning Objectives Q1. What problem does an ERP system solve? Q2. What are the elements of an ERP system? Q3.

More information

Life Sciences Contract Manufacturing Value Chain

Life Sciences Contract Manufacturing Value Chain Benefits Achieve computer systems validation with qualified cloud infrastructure Integrate quality directly into core business processes Improve supply chain governance and visibility Establish consistent

More information

Excellence in integrating LIMS and Life Sciences Supply Chain Management

Excellence in integrating LIMS and Life Sciences Supply Chain Management Excellence in integrating LIMS and Life Sciences Supply Chain Management by Michael Schmidt and Stefan Kubick Operational integration within the supply chain requires more than just state-of-the-art IT

More information

14595: Model Based Engineering for Embedded Test Software Requirements Development

14595: Model Based Engineering for Embedded Test Software Requirements Development Pursuant to ITAR 120.10, this document contains no technical data 14595: Model Based Engineering for Embedded Software Requirements Development James Brewer Architect Raytheon 25 Oct 2012 Copyright 2012

More information

Strategic Implantation of PAT : FDA Perspective

Strategic Implantation of PAT : FDA Perspective Strategic Implantation of PAT : FDA Perspective Moheb M. Nasr, Ph.D. CDER, FDA MOHEB.NASR@FDA.HHS.GOV IFPAC 2008 Strategic Implantation of PAT Baltimore, MD January 27, 2008 Outline The Desired State -

More information

INTEGRATED CONFIGURABLE EXCELLENCE. NWA Quality Information System. Manufacturing Intelligence for Intelligent Manufacturing

INTEGRATED CONFIGURABLE EXCELLENCE. NWA Quality Information System. Manufacturing Intelligence for Intelligent Manufacturing INTEGRATED CONFIGURABLE EXCELLENCE NWA Quality Information System Manufacturing Intelligence for Intelligent Manufacturing NWA Quality Information System Affordable quality automation Functionality NWA

More information

Themes & Key Points The Problem Statement

Themes & Key Points The Problem Statement Themes & Key Points The Problem Statement Post-approval changes are inevitable and essential, however, it is difficult to manage evolving requirements and timelines in every country to ensure continuous

More information

White Paper Cloud Strategy for Improving Legacy MRP & Supply Chain Processes

White Paper Cloud Strategy for Improving Legacy MRP & Supply Chain Processes White Paper Cloud Strategy for Improving Legacy MRP & Supply Chain Processes Abstract: A fundamental change is taking place in the nature and application of supply chain technologies, a change with profound

More information

Prepare for a more efficient SAP implementation: Take data issues off the critical path

Prepare for a more efficient SAP implementation: Take data issues off the critical path Prepare for a more efficient SAP implementation: Take data issues off the critical path Identify data risks before implementation with the Preliminary Data Assessment Appliance Preliminary Data Assessment

More information

Maximizing the Value of Novartis' GMP PI System with the Enterprise Agreement: San Carlos Site Case Study

Maximizing the Value of Novartis' GMP PI System with the Enterprise Agreement: San Carlos Site Case Study Maximizing the Value of Novartis' GMP PI System with the Enterprise Agreement: San Carlos Site Case Study Presented by Serge de Grandpré Hervé Bajolle Copyright 2015 OSIsoft, LLC Disclaimer "The information

More information

Current Hotspots during CMC Evaluation a European Regulatory Perspective

Current Hotspots during CMC Evaluation a European Regulatory Perspective www.pei.de Current Hotspots during CMC Evaluation a European Regulatory Perspective CMC Strategy Forum Japan 2018 3-4 December, Tokyo Steffen Gross, Head Section monoclonal - and polyclonal Antibodies

More information

Process development and basic GMP

Process development and basic GMP Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical

More information